Assess whether RWE can replace or only supplement an RCT (672cc7)

Situation

The desk packet is RWE protocol that may not meet regulator expectations after a boxed-warning proposal from the review division. Pharmacovigilance medical reviewer in a rare-disease team designing a pediatric plan has to name RWE can replace or Only supplement an RCT for this Pharma & Life Sciences Clinical and Evidence Strategy file.

Decision

Pharmacovigilance medical reviewer in a rare-disease team designing a pediatric plan must choose RWE can replace / Only supplement an RCT using RWE protocol that may not meet regulator expectations after a boxed-warning proposal from the review division.

Hypotheses to test

• Authorize RWE can replace now; RWE protocol that may not meet regulator expectations already has the discriminator after a boxed-warning proposal from the review division.
• Keep Only supplement an RCT in force until RWE protocol that may not meet regulator expectations is completed after a boxed-warning proposal from the review division for pharmacovigilance medical reviewer.
• Treat RWE protocol that may not meet regulator expectations as RWE can replace because both readings appear after a boxed-warning proposal from the review division.
• Refuse a Pharma & Life Sciences close: pharmacovigilance medical reviewer does not have the page RWE can replace or turns on in RWE protocol that may not meet regulator expectations.

Analysis required

• Check whether RWE protocol that may not meet regulator expectations supports the labeled claim pharmacovigilance medical reviewer would keep.
• Map FDA-response timing and owner in a rare-disease team designing a pediatric plan.
• Trace CMC, labeling, or pharmacovigilance facts in RWE protocol that may not meet regulator expectations after a boxed-warning proposal from the review division.
• For this Pharma & Life Sciences Clinical and Evidence Strategy file, read RWE protocol that may not meet regulator expectations against a boxed-warning proposal from the review division and write the one fact that would move RWE can replace or for pharmacovigilance medical reviewer.

Recommendation

Choose RWE can replace / Only supplement an RCT on this Pharma & Life Sciences / Clinical and Evidence Strategy packet (RWE protocol that may not meet regulator expectations after a boxed-warning proposal from the review division). The follow-on Clinical and Evidence Strategy action is what pharmacovigilance medical reviewer does next: implement the option, assign an owner, and log the missing fact.